Result Summary for APVF3031
| Protocol ID: | APVF3031 |
| Clinical Study ID: | APVF3031 |
| Official Title: | Multicentre, randomized, comparative, open, pilot study to assess efficacy and safety of a treatment with two protease inhibitors (GW433908 + Indinavir [IDV, Crixivan]) boosted by ritonavir in combination with nucleoside reverse transcriptase inhibitor (NRTI) in experienced HIV-1 infected subjects. |
| Phase: | Phase 3 |
| Study Indications or Diseases: |
|
| Generic Name: | fosamprenavir |
| Trade/Product Name: | lexiva;lexiva |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
